Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.59 USD | +7.87% | -1.29% | +7.49% |
Apr. 19 | US FDA mandates label updates on CAR-T cancer therapies | RE |
Apr. 05 | Bristol-Myers Squibb, 2seventy Bio Say FDA Approves Expansion of Myeloma Treatment's Indication | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.49% | 219M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- TSVT Stock
- News 2seventy bio, Inc.
- Transcript : 2seventy bio, Inc. Presents at Citi 2024 Virtual Oncology Leadership Summit, Feb-22-2024 12